Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Refarco is an Italian pharmaceutical company dedicated to the development, production, and marketing of a wide range of healthcare products, including prescription medicines, medical devices, and food supplements. Founded in 1994, the company focuses on providing high-quality therapeutic solutions across various areas such as gastroenterology, respiratory health, and pain management. Refarco operates with a strong emphasis on regulatory compliance and quality assurance, ensuring that its products meet stringent international standards. The company leverages its expertise in the Italian market to distribute both proprietary and licensed products, catering to the needs of healthcare professionals and patients alike. With a commitment to innovation and patient care, Refarco continues to expand its portfolio through strategic partnerships and internal development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REFARCO.